SC 13G/AAMENDMENTGDTCCIK 0001873093

CytoMed Therapeutics Ltd

Name: SEC EDGAR filing 0001477932-26-006422
Creator: CytoMed Therapeutics Ltd
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed October 23, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G/A? What it is and how to read one

Filing facts

Accession number: 0001477932-26-006422
Filer: CytoMed Therapeutics Ltd
Ticker: GDTC
CIK: 0001873093
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: October 23, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 23, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1873093/000147793226006422/0001477932-26-006422-index.htm ↗

Filer's full EDGAR submission history

EDGAR · CytoMed Therapeutics Ltd (0001873093) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001477932-26-006422.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.